emapalumab
Showing 1 - 5 of 5
Graft Failure Trial in Australia, Canada, Israel (Emapalumab)
Terminated
- Graft Failure
- Emapalumab
-
Melbourne, Australia
- +4 more
Jul 25, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
- Emapalumab
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
- Emapalumab
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,
Recruiting
- Primary Immune Regulatory Disorder
- +2 more
- Emapalumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 15, 2023
Primary Hemophagocytic Lymphohistiocytosis Trial in Worldwide (Emapalumab)
Active, not recruiting
- Primary Hemophagocytic Lymphohistiocytosis
- Emapalumab
-
Phoenix, Arizona
- +27 more
Nov 4, 2021